Small logo Subscribe to leading news on impact investing. Learn More
The Brief Originals Dealflow Signals The Impact Alpha Impact Voices Podcasts Agents of Impact Open
What's Next Capital on the Frontier Measure Better Investing in Racial Equity Beyond Trade-offs Impact en las Americas New Revivalists
Local and Inclusive Climate Finance Catalytic Capital Frontier Finance Best Practices Geographies
Slack Agent of Impact Calls Events Contribute
The Archive ImpactSpace The Accelerator Selection Tool Network Map
About Us FAQ Calendar Pricing and Payment Policy Privacy Policy Terms of Service Agreement Contact Us
Locavesting Entrepreneurship Gender Smart Return on Inclusion Good Jobs Creative economy Opportunity Zones Investing in place Housing New Schooled Well Being People on the Move Faith and investing Inclusive Fintech
Clean Energy Farmer Finance Soil Wealth Conservation Finance Financing Fish
Innovative Finance
Personal Finance Impact Management
Africa Asia Europe Latin America Middle East Oceania/Australia China Canada India United Kingdom United States
Subscribe Log In

Gates Foundation to invest in manufacturing facilities to accelerate COVID vaccine

ImpactAlpha, April 6 – The Gates Foundation announced in February that it was turning its attention to climate change and gender equity. That was pre-COVID.

The foundation now plans to build manufacturing facilities for seven of the most promising COVID vaccines to accelerate production even before their effectiveness is proven.

“It’ll be a few billion dollars we’ll waste on manufacturing for the constructs that don’t get picked because something else is better,” Bill Gates told The Daily Show’s Trevor Noah. But given the lives and trillions of dollars at stake, “it is worth it,” he said.

The foundation also has backed, with Wellcome and Mastercard, a $125 million vaccine accelerator.

You might also like...